Last synced on 23 May 2025 at 11:06 pm

Early Growth Response 1 (Egr) Fish Probe Kit

Page Type
Product Code
Definition
The egr1 fish probe kit is intended to detect deletion of the lsi egr1 probe target in bone marrow specimens and may be used, in addition to cytogenetics, other biomarkers, morphology, and other clinical information, at the time of diagnosis as an aid in determining the prognosis of acute myeloid leukemia (aml) patients.
Physical State
Device is a kit containing labeled FISH Probes
Technical Method
Detection of Early Growth Response Gene (EGR1) by fluorescence in-situ hybridization.
Target Area
Not applicable
Regulation Medical Specialty
Immunology
Review Panel
Pathology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.6040
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 866.6040 Gene expression profiling test system for breast cancer prognosis

§ 866.6040 Gene expression profiling test system for breast cancer prognosis.

(a) Identification. A gene expression profiling test system for breast cancer prognosis is a device that measures the ribonucleic acid (RNA) expression level of multiple genes and combines this information to yield a signature (pattern or classifier or index) to aid in prognosis of previously diagnosed breast cancer.

(b) Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Gene Expression Profiling Test System for Breast Cancer Prognosis.” See § 866.1(e) for the availability of this guidance document.

[72 FR 26291, May 9, 2007]

Early Growth Response 1 (Egr) Fish Probe Kit

Page Type
Product Code
Definition
The egr1 fish probe kit is intended to detect deletion of the lsi egr1 probe target in bone marrow specimens and may be used, in addition to cytogenetics, other biomarkers, morphology, and other clinical information, at the time of diagnosis as an aid in determining the prognosis of acute myeloid leukemia (aml) patients.
Physical State
Device is a kit containing labeled FISH Probes
Technical Method
Detection of Early Growth Response Gene (EGR1) by fluorescence in-situ hybridization.
Target Area
Not applicable
Regulation Medical Specialty
Immunology
Review Panel
Pathology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.6040
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 866.6040 Gene expression profiling test system for breast cancer prognosis

§ 866.6040 Gene expression profiling test system for breast cancer prognosis.

(a) Identification. A gene expression profiling test system for breast cancer prognosis is a device that measures the ribonucleic acid (RNA) expression level of multiple genes and combines this information to yield a signature (pattern or classifier or index) to aid in prognosis of previously diagnosed breast cancer.

(b) Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Gene Expression Profiling Test System for Breast Cancer Prognosis.” See § 866.1(e) for the availability of this guidance document.

[72 FR 26291, May 9, 2007]